Hot Pursuit     22-Mar-24
Biocon Ltd spurts 1.83%, gains for third straight session
Biocon Ltd is quoting at Rs 253.25, up 1.83% on the day as on 12:49 IST on the NSE. The stock is up 22.34% in last one year as compared to a 29.37% jump in NIFTY and a 59.35% jump in the Nifty Pharma index.

Biocon Ltd gained for a third straight session today. The stock is quoting at Rs 253.25, up 1.83% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.36% on the day, quoting at 22091.6. The Sensex is at 72819.71, up 0.25%. Biocon Ltd has slipped around 7.25% in last one month.

Meanwhile, Nifty Pharma index of which Biocon Ltd is a constituent, has slipped around 1.44% in last one month and is currently quoting at 18582.6, up 1.03% on the day. The volume in the stock stood at 34.89 lakh shares today, compared to the daily average of 60.4 lakh shares in last one month.

The benchmark March futures contract for the stock is quoting at Rs 255.75, up 1.81% on the day. Biocon Ltd is up 22.34% in last one year as compared to a 29.37% jump in NIFTY and a 59.35% jump in the Nifty Pharma index.

The PE of the stock is 0 based on TTM earnings ending December 23.

Previous News
  Biocon Ltd spurts 1.07%, gains for fifth straight session
 ( Hot Pursuit - 03-Jul-25   13:00 )
  Nifty above 25,550 mark; oil & gas shares jump
 ( Market Commentary - Mid-Session 03-Jul-25   10:39 )
  Biocon's biologics arm gets regulatory approval in EU for Denosumab biosimilars
 ( Hot Pursuit - 03-Jul-25   09:50 )
  Biocon Biologics receives EU marketing authorisation for Vevzuo® and Evfraxy® biosimilars of Denosumab
 ( Corporate News - 03-Jul-25   09:12 )
  Biocon's biologics arm gets Health Canada approval for aflibercept biosimilar 'Yesafili'
 ( Hot Pursuit - 27-Jun-25   12:18 )
  Biocon raises Rs 4,500 crore via QIP
 ( Hot Pursuit - 21-Jun-25   09:13 )
  Restaurant Brands Asia Ltd leads gainers in 'A' group
 ( Hot Pursuit - 19-Jun-25   12:00 )
  Biocon get facilities rated
 ( Corporate News - 18-Jun-25   09:41 )
  Indices drift lower in early trade; breadth positive
 ( Market Commentary - Mid-Session 17-Jun-25   09:37 )
  Biocon Ltd soars 3.52%, Gains for third straight session
 ( Hot Pursuit - 11-Jun-25   13:05 )
  Biocon gets CDSCO approval for Liraglutide drug substance
 ( Hot Pursuit - 03-Jun-25   08:23 )
Other Stories
  V2 Retail’s revenue climbs 51% YoY in Q1 FY26
  03-Jul-25   15:14
  Arkade Developers surges after acquiring Goregaon-based redevelopment project
  03-Jul-25   15:07
  VST Industries Ltd leads losers in 'A' group
  03-Jul-25   15:00
  CARE Ratings reaffirms ratings of India Shelter Finance at 'CARE AA-' with 'stable’' outlook
  03-Jul-25   14:56
  U. Y. Fincorp Ltd leads losers in 'B' group
  03-Jul-25   14:45
  Bajel Projects hits the roof after securing mega order from Power Grid Corporation
  03-Jul-25   14:41
  Volumes soar at DCM Shriram Ltd counter
  03-Jul-25   14:30
  REC Ltd down for fifth straight session
  03-Jul-25   13:35
  Persistent Systems appoints Shimona Chadha as CMO
  03-Jul-25   13:19
  Maruti Suzuki India Ltd gains for third straight session
  03-Jul-25   13:05
Back Top